* Effectiveness and reliability of TachoSil in cholecystectomy (elective and acute) * Evaluation of TachoSil in laparoscopic cholecystectomy * Risk profile of patient under anticoagulant therapy undergoing acute cholecystectomy * Pharmaco-economic evaluation * Recording of AE's/SAE's Considering the total number of cholecystectomies in Germany (170.000 cases/y), out of them about 75% laparoscopic and 10.000 conversions totally it seems urgent to record data about usage of TachoSil in such procedures. For the time being TachoSil is applied in about 2% of the gall bladder procedures. Aim is to evaluate a possible patient and procedure profile where TachoSil is most beneficial.
Study Type
OBSERVATIONAL
Enrollment
500
haemorrhages in cholecystectomy
Nycomed
Roskilde, Denmark
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.